200 related articles for article (PubMed ID: 30647184)
1. Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape.
Merayo-Chalico J; Barrera-Vargas A; Morales-Padilla S; la Garza RR; Vázquez-Rodríguez R; Campos-Guzmán J; Alcocer-Varela J; Sotomayor M; Abud-Mendoza C; Martínez-Martínez M; Colunga-Pedraza I; Uriarte-Hernández C; Acosta-Hernández R; Fajardo D; García-García C; Padilla-Ortíz D; Gómez-Martín D
J Rheumatol; 2019 Apr; 46(4):397-404. PubMed ID: 30647184
[TBL] [Abstract][Full Text] [Related]
2. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
[TBL] [Abstract][Full Text] [Related]
3. Asymptomatic Coronary Artery Calcifications in Men with Systemic Lupus Erythematosus.
Romero-Díaz J; Acosta-Hernández RI; Criales-Vera S; Kimura-Hayama E; Domínguez-Quintana M; Morán-Contla R; Núñez-Alvarez C; Lara-Reyes P; Aguilar-Salinas C; Sánchez-Guerrero J
J Rheumatol; 2018 May; 45(5):663-670. PubMed ID: 29545452
[TBL] [Abstract][Full Text] [Related]
4. Treatment pathways in an inception lupus cohort over the first three years.
Hanly JG; Sayani A; Doucette S; Iczkovitz S; Terres JAR
Lupus; 2017 Feb; 26(2):119-124. PubMed ID: 27365369
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
[TBL] [Abstract][Full Text] [Related]
6. Damage in systemic lupus erythematosus and its association with corticosteroids.
Zonana-Nacach A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
[TBL] [Abstract][Full Text] [Related]
7. Complete urological evaluation including sperm DNA fragmentation in male systemic lupus erythematosus patients.
Tiseo BC; Bonfá E; Borba EF; Munhoz GA; Wood G; Srougi M; Silva CA; Cocuzza M
Lupus; 2019 Jan; 28(1):59-65. PubMed ID: 30509155
[TBL] [Abstract][Full Text] [Related]
8. Lupus nephritis is associated with more corticosteroid-associated organ damage but less corticosteroid non-associated organ damage.
Joo YB; Won S; Choi CB; Bae SC
Lupus; 2017 May; 26(6):598-605. PubMed ID: 27687027
[TBL] [Abstract][Full Text] [Related]
9. Anti-Sm Antibody, Damage Index, and Corticosteroid Use Are Associated with Cardiac Involvement in Systemic Lupus Erythematosus: Data from a Prospective Registry Study.
Choe JY; Lee SS; Kwak SG; Kim SK
J Korean Med Sci; 2020 Jun; 35(21):e139. PubMed ID: 32476300
[TBL] [Abstract][Full Text] [Related]
10. Cerebral atrophy related to corticotherapy in systemic lupus erythematosus (SLE).
Zanardi VA; Magna LA; Costallat LT
Clin Rheumatol; 2001; 20(4):245-50. PubMed ID: 11529629
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
12. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics".
Pons-Estel BA; Catoggio LJ; Cardiel MH; Soriano ER; Gentiletti S; Villa AR; Abadi I; Caeiro F; Alvarellos A; Alarcón-Segovia D;
Medicine (Baltimore); 2004 Jan; 83(1):1-17. PubMed ID: 14747764
[TBL] [Abstract][Full Text] [Related]
13. Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort.
Nieto R; Quintana R; Zavala-Flores E; Serrano R; Roberts K; Catoggio LJ; García MA; Berbotto GA; Saurit V; Bonfa E; Borba EF; Lavras Costallat LT; Da Silva NA; Sato EI; Tavares Brenol JC; Massardo L; Neira OJ; Vázquez G; Guibert Toledano M; Pascual-Ramos V; Sauza Del Pozo MJ; Barile-Fabris LA; Amigo MC; García De La Torre I; Acevedo-Vásquez EM; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA; Pons-Estel GJ
Lupus; 2024 Apr; 33(4):340-346. PubMed ID: 38334100
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.
Hendler JV; de Souza L; de Freitas Zernow DC; Guimarães J; Bertotto T; Saldanha CF; Brenol JCT; Monticielo OA
Clin Rheumatol; 2017 Sep; 36(9):2005-2010. PubMed ID: 28653264
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study.
Merayo-Chalico J; Apodaca E; Barrera-Vargas A; Alcocer-Varela J; Colunga-Pedraza I; González-Patiño A; Arauz A; Abud-Mendoza C; Martínez-Martínez M; Gómez-Martín D
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):287-94. PubMed ID: 25804426
[TBL] [Abstract][Full Text] [Related]
16. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study.
Merayo-Chalico J; Gómez-Martín D; Piñeirúa-Menéndez A; Santana-De Anda K; Alcocer-Varela J
QJM; 2013 May; 106(5):451-7. PubMed ID: 23458779
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum?: a case control study.
Merayo-Chalico J; Demichelis-Gómez R; Rajme-López S; Aparicio-Vera L; Barrera-Vargas A; Alcocer-Varela J; Gómez-Martín D
Thromb Res; 2014 Nov; 134(5):1020-7. PubMed ID: 25257921
[TBL] [Abstract][Full Text] [Related]
18. Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study.
Yavuz S; Cansu DU; Nikolopoulos D; Crisafulli F; Antunes AM; Adamichou C; Reid S; Stagnaro C; Andreoli L; Tincani A; Moraes-Fontes MF; Mosca M; Leonard D; Jönsen A; Bengtsson A; Svenungsson E; Gunnarsson I; Dahlqvist SR; Sjöwall C; Bertsias G; Fanouriakis A; Rönnblom L
Semin Arthritis Rheum; 2020 Dec; 50(6):1387-1393. PubMed ID: 32229040
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
[TBL] [Abstract][Full Text] [Related]
20. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
